Literature DB >> 20788487

ANNOTATIONS.

.   

Abstract

Year:  1955        PMID: 20788487      PMCID: PMC1981600     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Pulmonary oedema due to salicylates, with report of a case.

Authors:  J SUTCLIFFE
Journal:  Br J Radiol       Date:  1955-06       Impact factor: 3.039

2.  Comparison of rescinnamine and reserpine as hypotensive agents.

Authors:  F H SMIRK; E G McQUEEN
Journal:  Lancet       Date:  1955-07-16       Impact factor: 79.321

3.  Treatment of hypertension; hypotensive drugs and mental changes.

Authors:  D C WALLACE
Journal:  Lancet       Date:  1955-07-16       Impact factor: 79.321

4.  Use of reserpine and Rauwolfia in psychoneuroses.

Authors:  A FOLKSON; A R MAY
Journal:  Br Med J       Date:  1955-11-05

5.  Psychosis apparently produced by reserpine.

Authors:  H A SCHROEDER; H M PERRY
Journal:  J Am Med Assoc       Date:  1955-10-29

6.  Depression and anxiety occurring during Rauwolfia therapy.

Authors:  J C MULLER; W W PRYOR; J E GIBBONS; E S ORGAIN
Journal:  J Am Med Assoc       Date:  1955-10-29

7.  Pulmonary oedema complicating the treatment of rheumatic carditis with sodium salicylate.

Authors:  D N PHEAR
Journal:  Arch Middx Hosp       Date:  1955-07

8.  Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

Authors:  E D FREIS
Journal:  N Engl J Med       Date:  1954-12-16       Impact factor: 91.245

9.  Rauwolfia serpentina (serpasil) in psychiatry.

Authors:  J D GLYNN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-08       Impact factor: 10.154

10.  Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil).

Authors:  R W WILKINS
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.